Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1671234rdf:typepubmed:Citationlld:pubmed
pubmed-article:1671234lifeskim:mentionsumls-concept:C0020102lld:lifeskim
pubmed-article:1671234lifeskim:mentionsumls-concept:C0596873lld:lifeskim
pubmed-article:1671234lifeskim:mentionsumls-concept:C0205359lld:lifeskim
pubmed-article:1671234pubmed:issue8737lld:pubmed
pubmed-article:1671234pubmed:dateCreated1991-3-6lld:pubmed
pubmed-article:1671234pubmed:abstractTextWe measured lymphocyte proliferation in the absence of antigenic stimulation in 45 HTLV-II infected, 9 HTLV-I infected, and 19 HTLV-I seronegative intravenous drug users (IVDU). Lymphocyte proliferation was higher in IVDUs infected with HTLV-II than in seronegative IVDUs but lower than among those infected with HTLV-I. Higher rates of proliferation were also associated with needle sharing, CD4+ and IL2R+ lymphocyte counts, and HTLV-I antibody titres.lld:pubmed
pubmed-article:1671234pubmed:languageenglld:pubmed
pubmed-article:1671234pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1671234pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1671234pubmed:statusMEDLINElld:pubmed
pubmed-article:1671234pubmed:monthFeblld:pubmed
pubmed-article:1671234pubmed:issn0140-6736lld:pubmed
pubmed-article:1671234pubmed:authorpubmed-author:JacobsonSSlld:pubmed
pubmed-article:1671234pubmed:authorpubmed-author:McFarlinD EDElld:pubmed
pubmed-article:1671234pubmed:authorpubmed-author:BlattnerW AWAlld:pubmed
pubmed-article:1671234pubmed:authorpubmed-author:ShawG MGMlld:pubmed
pubmed-article:1671234pubmed:authorpubmed-author:WiktorS ZSZlld:pubmed
pubmed-article:1671234pubmed:authorpubmed-author:WeissS HSHlld:pubmed
pubmed-article:1671234pubmed:authorpubmed-author:ShortyV JVJlld:pubmed
pubmed-article:1671234pubmed:authorpubmed-author:ReubenJ SJSlld:pubmed
pubmed-article:1671234pubmed:issnTypePrintlld:pubmed
pubmed-article:1671234pubmed:day9lld:pubmed
pubmed-article:1671234pubmed:volume337lld:pubmed
pubmed-article:1671234pubmed:ownerNLMlld:pubmed
pubmed-article:1671234pubmed:authorsCompleteYlld:pubmed
pubmed-article:1671234pubmed:pagination327-8lld:pubmed
pubmed-article:1671234pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:meshHeadingpubmed-meshheading:1671234-...lld:pubmed
pubmed-article:1671234pubmed:year1991lld:pubmed
pubmed-article:1671234pubmed:articleTitleSpontaneous lymphocyte proliferation in HTLV-II infection.lld:pubmed
pubmed-article:1671234pubmed:affiliationViral Epidemiology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.lld:pubmed
pubmed-article:1671234pubmed:publicationTypeJournal Articlelld:pubmed